Forward Citations = 26

Loading Chart...

1 inventor (with patents filed for the assignee):

Anthony W Czarnik (4 out of 32 patents)

4 patents: Sort by Forward Citations

1. 9023868 - Deuterium-enriched lenalidomide (2015-05-05),

2. 8669276 - Deuterium-enriched lenalidomide (2014-03-11),

3. 8304435 - Deuterium-enriched donepezil (2012-11-06),

4. 8288414 - Deuterium-enriched lenalidomide (2012-10-16),

Deuteria Pharmaceuticals, Inc. is a biotechnology company that specializes in the research and development of novel drugs for the treatment of various diseases. With a focus on deuteration technology, Deuteria aims to improve the efficacy, safety, and pharmacokinetics of existing drugs to address unmet medical needs. Their innovative approach has led to the creation of a robust pipeline of drug candidates in various stages of development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#42 in Andover, MA

#3,234 in Massachusetts

#59,049 in US

Andover, MA, United States of America

Deuteria Pharmaceuticals, Inc.

Forward Citations = 26

1 inventor:

Anthony W Czarnik (4 out of 32 patents)

Please report any incorrect information to support@idiyas.com